Health

  • December 12, 2025

    Sherwin-Williams Flicks Tobacco Fee Suit To Arbitration

    An Ohio federal judge refused Friday to toss a proposed class action from two Sherwin-Williams ex-workers who alleged an employee health plan tobacco surcharge violated nondiscrimination provisions in federal benefits law, finding while one claim could proceed in court, the dispute should first head to arbitration.

  • December 12, 2025

    11th Circ. Scrutinizes Qui Tam History In FCA Challenge

    The Eleventh Circuit Friday weighed both the history of whistleblower laws going back to the nation's founding and recent U.S. Supreme Court commentary on qui tam litigation in a closely watched challenge to the False Claims Act.

  • December 12, 2025

    Mississippi Litigator Joins Butler Snow From Adams & Reese

    Butler Snow LLP announced that an experienced litigation and appellate attorney has joined the firm's healthcare practice in Ridgeland, Mississippi, after a stint with Adams & Reese LLP.

  • December 12, 2025

    Molina Investor Sues Board Over Insurer's Guidance Cuts

    Executives and directors of health insurance provider Molina Healthcare were hit with a shareholder's derivative suit Friday accusing them of misleading investors about medical cost trends and internal controls before repeatedly slashing the company's 2025 earnings guidance.

  • December 12, 2025

    Higgs Fletcher Forms White Collar, Regs Enforcement Team

    San Diego-based law firm Higgs Fletcher & Mack LLP has launched a white collar crime and regulatory enforcement defense practice group, citing heightened regulatory scrutiny in the financial and healthcare sectors and rising enforcement risks for licensed professionals and institutions.

  • December 11, 2025

    LAPD Settles Suit Over Pot Raid That Destroyed MRI Machine

    An X-ray and imaging clinic in North Hollywood looks ready to settle a lawsuit accusing the Los Angeles Police Department of executing a raid on the erroneous assumption that it was an illicit marijuana grow site, destroying an MRI machine with a rifle in the process.

  • December 11, 2025

    LA Bellwether Jury To Decide If J&J Hid Talc Risk For Decades

    An attorney for one of two women who claim Johnson & Johnson's talcum products caused their ovarian cancer told a California jury Thursday in a bellwether trial's closing arguments that the company hid the health risks of talc for decades, while the company's attorney insisted the science is on their side.

  • December 11, 2025

    Epic Systems Is Monopolizing EHR Market, Texas AG Suit Says

    Texas Attorney General Ken Paxton hit Epic Systems Corp. with an antitrust suit in state court on Wednesday alleging the company is illegally seeking to monopolize markets for electronic health records software.

  • December 11, 2025

    Trial Record Backs Gender-Affirming Care, Ohio Justices Told

    A group of transgender youths and their families urged Ohio's highest court to affirm their win overturning state restrictions on gender-affirming care, arguing undisputed evidence at trial backed their arguments on the safety and effectiveness of the treatment.

  • December 11, 2025

    Life Insurers Exempt From Ill. Genetic Privacy Law, Court Says

    An Illinois state appeals court affirmed the dismissal of a man's suit claiming two State Farm life insurers violated Illinois' genetic information privacy law, finding a section barring the use of genetic protected health information for underwriting purposes does not apply to life insurance companies.

  • December 11, 2025

    Failed ACA Credit Extension Votes Leave Costs In Limbo

    The Senate failed Thursday to pass procedural votes on two healthcare proposals to address the upcoming lapse in the Affordable Care Act's enhanced premium tax credits, including a proposal by Democrats to extend the subsidies for three years.

  • December 11, 2025

    DOJ-UnitedHealth Deal Requiring Home Health Sale OK'd

    A Maryland federal judge signed off on the U.S. Department of Justice settlement resolving its challenge to UnitedHealth's $3.3 billion acquisition of home health and hospice company Amedisys, under a deal requiring the sale of least 164 locations across 19 states.

  • December 11, 2025

    Group Seeks Cannabis Reclassification Regarding Tax Status

    Cannabis shouldn't be categorized as a Schedule 1 or 2 drug, so tax law regarding the sale of illegal drugs shouldn't be applied to cannabis sales, a coalition of cannabis industry groups told the U.S. Tax Court in an amicus brief Thursday.

  • December 11, 2025

    EEOC Challenges Care Co.'s Bid For Win In Harassment Suit

    The U.S. Equal Employment Opportunity Commission is pushing back on a nursing home and rehabilitation center operator's bid for a pretrial win in a suit alleging it failed to act when a nurse was sexually harassed by her supervisor, saying that several disputed facts require a jury to weigh in.

  • December 11, 2025

    Elevance Health Adds Former Pfizer GC To Its Board

    Insurer Elevance Health has appointed former Pfizer Inc. general counsel Amy Schulman, currently a managing partner of Polaris Partners, to serve on its board of directors.

  • December 11, 2025

    Sidley Guides Diagnostic Imaging Firm Lumexa's $463M IPO

    Private equity-backed diagnostic imaging provider Lumexa Imaging Holdings Inc., led by Sidley Austin LLP, began trading Thursday on the Nasdaq Global Select Market after pricing a $463 million initial public offering.

  • December 11, 2025

    6th Circ. Panel Shows No Leanings On PBM Jurisdiction Fight

    A Sixth Circuit appeals panel gave few hints Thursday on whether it would send back to state court a lawsuit from Ohio alleging that pharmacy benefit managers were driving up prescription prices through rebate schemes. 

  • December 11, 2025

    4 Firms Guide As Arcline Exits Medical Tech Co. In $685M Deal

    Perimeter Solutions Inc. has agreed to acquire Medical Manufacturing Technologies LLC from Arcline Investment Management for approximately $685 million in cash, including certain tax benefits.

  • December 10, 2025

    'Crazy' To Link Talc With Ovarian Cancer, J&J Expert Says

    Johnson & Johnson rested its defense Wednesday in a Los Angeles bellwether trial over claims its talc products caused two women's ovarian cancer, with a gynecologic oncologist appearing as its last witness and telling the jury the idea of talc used for feminine hygiene reaching the ovaries is "crazy."

  • December 10, 2025

    Calif. Panel Reinstates Child Porn Rap Despite Abuse History

    A man who was abused as a child and raped as an adult cannot escape a child pornography conviction by arguing the abuse he endured led to the offense, a California state appeals court has ruled, finding in a reversal that his many traumas made it hard to ascertain a direct link to his crime.

  • December 10, 2025

    Kaiser Asks 9th Circ. To Make Nurses Arbitrate Wage Claims

    Kaiser Foundation Health Plan and a staffing company urged the Ninth Circuit on Wednesday to force traveling nurses to arbitrate their claims that they were cheated out of compensation, saying a judge erred when he found the agreement unconscionable due to a potentially confusing fee shifting provision.

  • December 10, 2025

    HealthEC Data Hack Class Seeks OK Of $5.5M Privacy Deal

    Over 1.6 million patients affected by HealthEC's cybersecurity attack in 2023 asked a New Jersey magistrate judge for her final stamp of approval on a $5.48 million class action settlement, arguing Monday the resolution includes additional, significant benefits like Medical Shield Complete which protects them from healthcare-related fraud. 

  • December 10, 2025

    Diagnostic Co. Agrees To Oversight Reforms In Derivative Suit

    A California federal judge has granted preliminary approval to a deal ending shareholder derivative claims that diagnostics company CareDx's executives and directors damaged the company by concealing its scheme to inflate its testing services revenue.

  • December 10, 2025

    Teva Pulls 200 Patents From Orange Book Amid FTC Probe

    The Federal Trade Commission said Wednesday an investigation it conducted into Teva Pharmaceuticals prompted the company to remove over 200 patents from the U.S. Food and Drug Administration's Orange Book.

  • December 10, 2025

    Courts Let Military Ban Trans, HIV-Positive Troops For Now

    Two federal appellate courts have cleared the federal government to enforce a pair of controversial policies restricting transgender and HIV-positive people from serving in the military, with each lifting trial court blockades on the rules while litigation challenging them plays out.

Expert Analysis

  • Series

    Building With Lego Makes Me A Better Lawyer

    Author Photo

    Building with Lego has taught me to follow directions and adapt to unexpected challenges, and in pairing discipline with imagination, allows me to stay grounded while finding new ways to make complex deals come together, says Paul Levin at Venable.

  • Series

    Law School's Missed Lessons: Networking 101

    Author Photo

    Cultivating a network isn't part of the law school curriculum, but learning the soft skills needed to do so may be the key to establishing a solid professional reputation, nurturing client relationships and building business, says Sharon Crane at Practising Law Institute.

  • Defeating Estoppel-Based Claims In Legal Malpractice Actions

    Author Photo

    State supreme court cases from recent years have addressed whether positions taken by attorneys in an underlying lawsuit can be used against them in a subsequent legal malpractice action, providing a foundation to defeat ex-clients’ estoppel claims, says Christopher Blazejewski at Sherin and Lodgen.

  • How Cos. Can Prep For Tightened Calif. Data Breach Notices

    Author Photo

    Amid California's recent enactment of S.B. 446, which significantly amends the state's data breach notification laws, companies should review and update their incident response plans by establishing processes to document and support any delayed notification, and ensure the notifications' accuracy, say Mark Krotoski and Alexandria Marx at Pillsbury.

  • Employer Considerations After 11th Circ. Gender Care Ruling

    Author Photo

    The Eleventh Circuit's en banc decision in Lange v. Houston County, Georgia, finding that a health plan did not violate Title VII by excluding coverage for gender-affirming care, shows that plans must be increasingly cognizant of federal and state liability as states pass varying mandates, say attorneys at Miller & Chevalier.

  • Series

    The Biz Court Digest: How It Works In Massachusetts

    Author Photo

    Since its founding in 2000, the Massachusetts Business Litigation Session's expertise, procedural flexibility and litigant-friendly case management practices have contributed to the development of a robust body of commercial jurisprudence, say James Donnelly at Mirick O’Connell, Felicia Ellsworth at WilmerHale and Lisa Wood at Foley Hoag.

  • How Healthcare Practices Can Prepare For ICE Visits

    Author Photo

    Healthcare providers that may face encounters with immigration enforcement should familiarize themselves with compliance obligations beyond ensuring employment authorization, and mitigate risk by establishing clear policies and specific procedures that safeguard patient rights and manage staff interactions with agents, say attorneys at Roetzel & Andress.

  • Adapting To Calif.'s Enhanced Regulation Of PE In Healthcare

    Author Photo

    New California legislation enhances oversight on the role of private equity groups and hedge funds in healthcare transactions, featuring both a highly targeted nature and vague language that will require organizations to carefully evaluate existing practices, says Andrew Demetriou at Husch Blackwell.

  • Why Appellees Should Write Their Answering Brief First

    Author Photo

    Though counterintuitive, appellees should consider writing their answering briefs before they’ve ever seen their opponent’s opening brief, as this practice confers numerous benefits related to argument structure, time pressures and workflow, says Joshua Sohn at the U.S. Department of Justice.

  • Navigating DEA Quotas: Key To Psychedelics Industry Growth

    Author Photo

    As new compounds like DOI enter the Schedule I landscape, manufacturers who anticipate U.S. Drug Enforcement Administration quota regulations, and build quota management into their broader strategy, will be best equipped to meet the growing demand, say Kimberly Chew at Husch Blackwell and Jaime Dwight at Promega.

  • Federal Acquisition Rules Get Measured Makeover

    Author Photo

    The Trump administration's promised overhaul of the Federal Acquisition Regulation is not a revolution in rules, but a meaningful recalibration of procurement practice that gives contracting officers more space to think, to tailor and to try, say attorneys at Mayer Brown.

  • Series

    Mindfulness Meditation Makes Me A Better Lawyer

    Author Photo

    Mindful meditation enables me to drop the ego, and in helping me to keep sight of what’s important, permits me to learn from the other side and become a reliable counselor, says Roy Wyman at Bass Berry.

  • Lessons From 7th Circ. Decision Affirming $183M FCA Verdict

    Author Photo

    The Seventh Circuit's decision to uphold a $183 million False Claims Act award against Eli Lilly engages substantively with recurring materiality and scienter questions and provides insights into appellate review of complex trial court judgments, say Ellen London at London & Naor, Li Yu at Bernstein Litowitz and Kimberly Friday at Osborn Maledon.

  • AI Litigation Tools Can Enhance Case Assessment, Strategy

    Author Photo

    Civil litigators can use artificial intelligence tools to strengthen case assessment and aid in early strategy development, as long as they address the risks and ethical considerations that accompany these uses, say attorneys at Barnes & Thornburg.

  • Attys Beware: Generative AI Can Also Hallucinate Metadata

    Author Photo

    In addition to the well-known problem of AI-generated hallucinations in legal documents, AI tools can also hallucinate metadata — threatening the integrity of discovery, the reliability of evidence and the ability to definitively identify the provenance of electronic documents, say attorneys at Law & Forensics.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.